Dr. Navid Djassemi, Hematology

Dr. Djassemi is a board certified pediatric hematologist who treats children at CHOC Hospital in Orange and specializes in Hematology/Bone Marrow Transplantation and Cellular Therapy.

Location

CHOC Specialists, Hematology
1201 W. La Veta Ave
Orange, CA 92868
phone: 714-509-5459
fax: 714-509-8771

Education

• Medical School
  Ross University School of Medicine – Dominica, Miramar, FL
• Residency
  Hackensack University Medical Center, Hackensack, NJ
• Fellowship
  Rady Children’s Hospital, San Diego, CA
  Bone Marrow Transplantation and Cellular Therapy at National Institutes of Health/Children’s National Hospital, Washington, DC

Publications

“The Spontaneous Neoantigen-Specific CD4+ T Cell Response to a Growing Tumor is Functionally and Phenotypically Diverse”
Griswold R, Brightman S, Zavala KS, Ordaz-Arias M, Djassemi N, Thota R, Naradikian M, Dose H, Alarcon S, Pandurangan V, Peters B, Miller A, Cohen E, Schoenberger S. J Immunother Cancer. Sept 2025. PMID: 40907998

“Harnessing Viral-Specific T Cells:  Expanding Therapeutic Strategies Across Diverse Populations”
Djassemi N, Hanisch B, Motta C, Maghzian N, Vatsayan A, Durkee-Shock J, Keller M. Review Article, Blood Adv.  August 2025. PMID: 40864193

“Outcome Analysis Post Virus-Specific T Cell Therapy for the Treatment of Adenoviremia in Immunocompromised Pediatric Patients.”
Djassemi N, Kinoshita H, Maghzian N, Datar A, Joy E, McCann C, Shibli A, Davila Saldana BJ, Hoq F, Hanley P, Pulsipher M, Bollard C, Keller M. American Society for Transplantation and Cellular Therapy, Feb;31(2): S221 – S222. American Society for Transplantation and Cellular Therapy Conference (ASTCT) 2025 Conference.

“Improving the Standardization of Outpatient Antibiotic Administration in Children with Cancer and Fever”
Djassemi N, Lee K, Aristizabal P, Bush K. “Improving the Standardization of Outpatient Antibiotic Administration in Children with Cancer and Fever.” Pediatric Blood & Cancer Pediatric Blood & Cancer Jun;71(S2):1545-5009. Quality Improvement Initiative. American Society of Pediatric Hematology-Oncology (ASPHO) 2024 Conference.

“Complicated Nocardiosis in X-linked CYBB CGD after MSD HSCT”
Djassemi N, Davila BJ. Case Report, Clinical Immunology Society (CIS), Summer School 2024 Conference

“Improving the Standardization of Outpatient Antibiotic Administration in Children with Cancer and Fever”
Djassemi N, Lee K, Aristizabal P, Bush K. “Improving the Standardization of Outpatient Antibiotic Administration in Children with Cancer and Fever.” Pediatric Blood & Cancer Pediatric Blood & Cancer Jun;71(S2):1545-5009. Quality Improvement Initiative. American Society of Pediatric Hematology-Oncology (ASPHO) 2024 Conference.

“Rare Renal Complications in Two Hispanic children with Newly Diagnosed Acute Myeloid Leukemia”
Sridhar S, Djassemi N, Miller R, Shayan K, Inguli E, Ganesan A, Aristizabal P. Case Report, Children’s Oncology Group (COG) 2022 Conference

“Improving the Standardization of IV Antibiotic Administration in Children with Cancer Presenting with Fever and Possible Neutropenia in the Outpatient Oncology Clinic”
Djassemi N, Fox A, Lee K, Bush K, Aristizabal P. UCSD Conference Proceedings Journal. May 2023

“Is There a Utility of ¹⁸F-FDG PET Scan Before Surgery in Breast Cancer? A 15-year Overall Survival Analysis”
Perrin J, Farid K, Parijs HV, Gorobets O, Vinh-Hung V, Nguyen N, Djassemi N, Ridder M, Everaert H. World Journal of Clinical Oncology, April 2022. PMID: 35582655

“A Rare Case of Secondary HLH Due to Vaccine-Strain Measles in a Young Child With Hepatoblastoma”
Kulatti A, Djassemi N, Yu H, Pong A, Choo S, Paul M. “A Rare Case of Secondary HLH Due to Vaccine-Strain Measles In A Young Child With Hepatoblastoma.” Pediatric Blood & Cancer Jun;69(S2):1545-5009.  Case Report, American Society of Pediatric Hematology-Oncology (ASPHO) 2022 Conference

“Hepatosplenic T-cell Lymphoma in an Adolescent with Previously Undiagnosed UNC13D-Mutated FHL Type 3”
Djassemi N, Yang X, Bhattacharyya P, Hung I, Gillio A, Appel B. “Hepatosplenic T-cell Lymphoma in an Adolescent with Previously Undiagnosed UNC13D-Mutated FHL Type 3.” Pediatric Blood & Cancer, Jun;69(S2):1545-5009. Case Report, American Society of Pediatric Hematology-Oncology (ASPHO) 2022 Conference

“Day 8 Minimal Residual Disease of 67% In A Child with Standard Risk B-Lymphoblastic Leukemia”
Djassemi N, Appel B. “Day 8 Minimal Residual Disease of 67% In A Child with Standard Risk B-Lymphoblastic Leukemia.” Pediatric Blood & Cancer, Jun;67(S2):381. Case Report, American Society of Pediatric Hematology-Oncology (ASPHO)

“Examining the Evolving Utility of 18F-PET/CT in Breast Cancer Recurrence”
Djassemi N, Rampey S, Motiani J. “Examining The Evolving Utility of 18FDG-PET/CT in Breast Cancer Recurrence.” Translational Cancer Research, Radiotherapy for Breast Cancer in Advanced Age, Jan;9(I):S116-S121. PMID: 35117953

“Thrombocytopenia and Eczema due to a Novel RUNX1 Mutation” 
Djassemi N, Keel S, Mandell J, King M.C., Walsh T, Casadei S, Wu D, Shimamura A, Appel B. “Thrombocytopenia And Eczema Due To A Novel RUNX1 Mutation.” Pediatric Blood & Cancer, Jun;66(S2):351.  Case Report, American Society of Pediatric Hematology-Oncology (ASPHO) 2019 Conference

“Preoperative [18]Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Early Stage Breast Cancer: Rates of Distant Metastases”
Vinh-Hugh V, Everaert H, Farid K, Djassemi N, Nguyen N. “Preoperative FDG-PET in Early Breast Cancer, Evidence & Controversies.”  World Journal of Radiology. July 2017. PMID: 28794827